The importance of Ras in drug resistance in cancer-Reference-Cited by-同舟云学术

The importance of Ras in drug resistance in cancer

Published:2021-04-06 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Healy Fiona M.¹,Prior Ian A.²,MacEwan David J.¹

Affiliation:

1. Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB) University of Liverpool Liverpool UK

2. Department of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology (ISMIB) University of Liverpool Liverpool UK

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15420

Reference221 articles.

1. Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics and computational studies of chabamide F and chabamide G for breast cancer and their probable mechanisms of action;Scientific Reports;2024-08-27

2. Unveiling hidden connections in omics data via pyPARAGON: an integrative hybrid approach for disease network construction;Briefings in Bioinformatics;2024-07-25

3. Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023);Expert Opinion on Therapeutic Patents;2024-02

4. The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues;NAR Cancer;2024-01-09

5. Novel Strategies for Overcoming Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024